AKBA Akebia Therapeutics, Inc. - Common Stock
AKBA Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
AKBA Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
AKBA Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
- Starker Kauf 5 45,5%
- Kauf 5 45,5%
- Halten 1 9,1%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
5 Analysten · 2026-08-15Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $-0.03 | $-0.04 | 0.01% |
| 31. März 2026 | $-0.03 | $-0.03 | -0.00% |
| 31. Dezember 2025 | $-0.05 | $-0.03 | -0.02% |
| 30. September 2025 | $0.00 | $-0.02 | 0.02% |
| 30. Juni 2025 | $0.00 | $-0.02 | 0.02% |
| 31. März 2025 | $0.03 | $-0.05 | 0.08% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| AKBA | $427M | -80.5 | 47.5% | -2.3% | -17.3% | — |
| CNXU | — | — | — | — | — | — |
| GLSI | $300M | -14.7 | — | — | -2159.7% | — |
| PYXS | $72M | -0.9 | -14.2% | -574.5% | -112.9% | — |
| RCEL | $105M | -2.0 | 11.5% | -67.8% | 328.9% | 82.1% |
| TARA | $286M | -4.0 | — | — | -33.7% | — |
| ALEC | $172M | -1.1 | -79.1% | -679.2% | -280.7% | — |
| EBS | $644M | 13.3 | -28.8% | 7.1% | 9.9% | — |
| ARCT | $174M | -2.6 | -46.1% | -80.2% | -29.6% | — |
| NBP | — | — | — | — | — | — |
| IMUX | — | -0.9 | — | — | — | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 16
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $236M | $160M | $195M | $292M | $212M | $295M | $335M | $208M | $181M | $2M | $0 | $0 | |
| Cost of Revenue | $39M | $63M | $74M | $86M | $151M | $296M | $145M | $8M | · | · | · | · | |
| R&D Expense | $62M | $38M | $63M | $130M | $148M | $218M | $323M | $291M | $231M | $116M | $43M | $23M | |
| SG&A Expense | $107M | $107M | $100M | $139M | $174M | $154M | $149M | $87M | $27M | $22M | $18M | $15M | |
| Operating Expenses | $173M | $147M | $167M | $288M | $325M | $376M | $476M | $378M | $258M | $138M | $62M | $38M | |
| Operating Income | $23M | $-50M | $-46M | $-81M | $-265M | $-378M | $-286M | $-178M | $-77M | $-136M | $-62M | $-38M | |
| Interest Income | · | · | · | · | · | · | · | · | · | $901.0K | $510.0K | $206.0K | |
| Other Non-op | $58.0K | $94.0K | $887.0K | $3M | $2M | $2M | $-794.0K | $81.0K | $204.0K | $-188.0K | $287.0K | $700.0K | |
| Pretax Income | $-4M | $-69M | $-52M | $-94M | $-282M | $-385M | $-286M | $-172M | $-74M | $-136M | · | · | |
| Income Tax | $2M | $0 | $0 | $0 | $0 | $0 | $-7M | $-28M | · | · | · | · | |
| Net Income | $-5M | $-69M | $-52M | $-94M | $-282M | $-385M | $-280M | $-144M | $-74M | $-136M | $-61M | $-37M | |
| EPS (Basic) | $-0.02 | $-0.33 | $-0.28 | $-0.52 | $-1.70 | $-2.78 | $-2.36 | · | · | · | · | · | |
| EPS (Diluted) | $-0.02 | $-0.33 | $-0.28 | $-0.52 | $-1.70 | $-2.78 | $-2.36 | · | · | · | · | · | |
| Shares (Basic) | 257,157,782 | 210,946,658 | 187,465,448 | 182,782,680 | 165,949,695 | 138,463,152 | 118,395,919 | · | · | · | · | · | |
| Shares (Diluted) | 257,157,782 | 210,946,658 | 187,465,448 | 182,782,680 | 165,949,695 | 138,463,152 | 118,395,919 | · | · | · | · | · | |
| EBITDA | $23M | $-50M | $-46M | $-79M | $-263M | $-374M | $-284M | $-177M | $-79M | $-136M | $-62M | $-38M |
Bilanz 29
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $185M | $52M | $43M | $90M | $150M | $229M | $147M | $105M | $70M | $187M | $50M | $33M | |
| Short-term Investments | · | · | · | · | · | · | · | · | $248M | $73M | $89M | $76M | |
| Receivables | $47M | $34M | $39M | $40M | $52M | $27M | $39M | $17M | $34M | $34M | · | $48.0K | |
| Inventory | $16M | $16M | $16M | $22M | $37M | $61M | $116M | $114M | · | · | · | · | |
| Prepaid Expense | $5M | $11M | $20M | $33M | $33M | $15M | $7M | $16M | $6M | $2M | $3M | $2M | |
| Other Current Assets | $4M | $7M | $6M | $17M | · | · | · | · | · | · | · | · | |
| Current Assets | $253M | $114M | $118M | $185M | $271M | $371M | $310M | $468M | $358M | $296M | $141M | $110M | |
| PP&E (Net) | $1M | $2M | $4M | $5M | $7M | $9M | $10M | $8M | $4M | $3M | $540.0K | $210.0K | |
| PP&E (Gross) | · | · | · | $15M | $14M | $14M | $14M | $10M | $5M | $3M | $687.0K | $261.0K | |
| Accum. Depreciation | · | · | · | $9M | $8M | $6M | $4M | $2M | $1M | $442.0K | $147.0K | $51.0K | |
| Goodwill | $59M | $59M | $59M | $59M | $59M | $55M | $55M | $55M | · | · | · | · | |
| Intangibles | · | $0 | $36M | $72M | $108M | $144M | $291M | $328M | · | · | · | · | |
| Other Non-current Assets | $60M | $37M | $12M | $5M | $50M | $38M | $76M | $137M | $2M | $1M | $1M | $305.0K | |
| Total Assets | $377M | $221M | $242M | $356M | $529M | $644M | $771M | $997M | $364M | $300M | $143M | $111M | |
| Accounts Payable | $21M | $15M | $15M | $18M | $34M | $41M | $39M | $43M | $7M | $2M | $2M | $2M | |
| Accrued Liabilities | $122M | $63M | $68M | $76M | $109M | $131M | $129M | $151M | $52M | $30M | $10M | $5M | |
| Current Liabilities | $163M | $81M | $100M | $130M | $261M | $187M | $208M | $266M | $141M | $114M | $12M | $7M | |
| Capital Leases | $0 | $4M | $9M | $29M | $34M | $25M | $28M | · | · | · | · | · | |
| Other Non-current Liabilities | $2M | $5M | $9M | $16M | $84M | $61M | $30M | $30M | $22.0K | $27.0K | $5.0K | $32.0K | |
| Total Liabilities | $344M | $270M | $272M | $351M | $455M | $397M | $376M | $361M | $242M | $232M | $12M | $7M | |
| Long-term Debt | $48M | $39M | $35M | $66M | $98M | $96M | $76M | · | · | · | · | · | |
| Total Debt | $48M | $39M | $35M | · | $98M | $96M | $76M | · | · | · | · | · | |
| Common Stock | $2.0K | $2.0K | $2.0K | $2.0K | $1.0K | $1.0K | $1.0K | $1.0K | $0 | $0 | $0 | $0 | |
| Retained Earnings | $-1.68B | $-1.68B | $-1.61B | $-1.56B | $-1.46B | $-1.18B | $-794M | $-514M | $-371M | $-297M | $-161M | $-101M | |
| Treasury Stock | · | · | · | · | · | · | · | · | · | · | $162.0K | $162.0K | |
| AOCI | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $13.0K | $0 | $-261.0K | $-442.0K | $-42.0K | $-234.0K | $-56.0K | |
| Stockholders' Equity | $33M | $-49M | $-31M | $5M | $74M | $244M | $393M | $636M | $123M | $68M | $131M | $104M | |
| Liabilities + Equity | $377M | $221M | $242M | $356M | $529M | $644M | $771M | $997M | $364M | $300M | $143M | $111M | |
| Shares Outstanding | 265,424,818 | 224,848,992 | 194,582,539 | 184,135,714 | 177,000,963 | 148,074,085 | 121,674,568 | 116,887,518 | 47,612,619 | 38,615,709 | 30,662,218 | 20,370,624 |
Cashflow 17
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | $2M | $2M | $2M | $2M | $899.0K | $617.0K | $296.0K | $96.0K | $49.0K | |
| Stock-based Comp | $11M | $8M | $9M | $18M | $23M | $24M | $12M | $19M | $9M | $6M | $5M | $6M | |
| Deferred Tax | $0 | $0 | $0 | $0 | $0 | $0 | $-7M | $-28M | $0 | $0 | $0 | $0 | |
| Amort. of Intangibles | $0 | $36M | $36M | $36M | $36M | $33M | $36M | $2M | · | · | · | · | |
| Restructuring | $0 | $58.0K | $181.0K | $16M | $0 | $0 | · | · | · | · | · | · | |
| Other Non-cash | · | · | · | $2M | $5M | $247M | $15M | $55M | $11M | $188M | · | · | |
| Operating Cash Flow | $68M | $-41M | $-23M | $-73M | $-253M | $-110M | $-257M | $-97M | $-56M | $58M | $-52M | $-27M | |
| CapEx | $291.0K | $33.0K | $0 | $114.0K | $59.0K | $317.0K | $7M | $2M | $2M | $3M | $414.0K | $229.0K | |
| Investing Cash Flow | $-8M | $-33.0K | $0 | $-114.0K | $40M | $-40M | $211M | $37M | $-177M | $13M | · | · | |
| Debt Issued | · | · | · | $0 | $0 | $20M | $78M | $0 | · | · | · | · | |
| Net Debt Issued | · | · | · | $0 | $0 | $20M | $78M | · | · | · | · | · | |
| Stock Issued | · | · | · | · | · | · | · | $468M | $373M | · | · | $104M | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | · | · | $162.0K | |
| Net Stock Activity | · | · | · | · | · | · | · | $468M | $373M | · | · | $104M | |
| Financing Cash Flow | $73M | $50M | $-25M | $15M | $134M | $232M | $89M | $97M | $116M | $67M | · | · | |
| Net Change in Cash | $133M | $9M | $-49M | $-59M | $-79M | $81M | $43M | $36M | $-117M | $138M | $17M | $12M | |
| Free Cash Flow | $68M | $-41M | $-23M | $-73M | $-253M | $-111M | $-264M | $-99M | $-58M | $55M | $-53M | $-28M |
Rentabilität 7
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 10.0% | -31.5% | -23.8% | -27.6% | -124.2% | -127.5% | -85.5% | -85.8% | · | · | · | · | |
| Net Margin | -2.3% | -43.3% | -26.7% | -32.2% | -132.4% | -129.8% | -83.5% | -69.1% | · | · | · | · | |
| Pretax Margin | -1.6% | -43.3% | -26.7% | -32.2% | -132.4% | -129.8% | -85.5% | -82.8% | · | · | · | · | |
| EBITDA Margin | 10.0% | -31.5% | -23.8% | -27.1% | -123.3% | -126.8% | -84.8% | -85.3% | · | · | · | · | |
| ROA | -1.8% | -30.0% | -19.9% | · | -48.4% | -54.2% | -31.6% | -21.1% | -23.2% | -61.3% | -47.8% | -50.8% | |
| ROE | -17.3% | 139.4% | 148.3% | · | -264.8% | -135.6% | -64.9% | -36.9% | -82.1% | -136.3% | -51.7% | 322.1% | |
| ROIC | 41.7% | · | · | · | -152.5% | -109.4% | -59.4% | -23.4% | · | · | · | · |
Liquidität & Solvenz 4
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.6 | 1.4 | 1.2 | · | 1.1 | 2.0 | 1.5 | 1.8 | 2.5 | 2.6 | 11.9 | 16.0 | |
| Quick Ratio | 1.4 | 1.1 | 0.8 | · | 0.8 | 1.4 | 0.9 | 0.5 | 2.4 | 2.3 | 11.7 | 15.8 | |
| Debt / Equity | 1.5 | -0.8 | -1.1 | · | 1.3 | 0.4 | 0.2 | · | · | · | · | · | |
| LT Debt / Equity | 1.5 | -0.8 | -0.6 | · | 0.0 | 0.4 | 0.2 | · | · | · | · | · |
Effizienz 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.7 | 0.7 | · | 0.4 | 0.4 | 0.4 | 0.3 | · | · | 0.0 | 0.0 | |
| Inventory Turnover | 2.5 | 4.0 | 4.1 | · | 3.1 | 3.3 | 0.9 | 0.1 | · | · | · | · | |
| Receivables Turnover | 5.8 | 4.3 | 6.7 | · | 5.5 | 9.0 | 12.1 | 8.2 | · | · | · | 0.0 |
Wachstumsraten 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 47.5% | -17.7% | -33.5% | 38.2% | -28.2% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -6.9% | -8.9% | -12.9% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -4.3% | · | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM) 14
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $236M | $160M | $195M | $292M | $212M | $295M | $335M | $208M | $181M | $2M | $0 | $0 | |
| Net Income TTM | $-5M | $-69M | $-52M | $-94M | $-282M | $-385M | $-280M | $-144M | $-74M | $-136M | $-61M | $-37M | |
| Market Cap | $427M | $427M | $241M | · | $400M | $415M | $769M | $646M | $708M | $402M | $396M | $237M | |
| Enterprise Value | $291M | $414M | $233M | · | $348M | $282M | $697M | · | · | · | · | · | |
| P/E | -80.5 | -5.8 | -4.4 | -1.1 | -1.3 | -1.0 | -2.7 | -3.0 | -8.0 | · | · | · | |
| P/S | 1.8 | 2.7 | 1.2 | · | 1.9 | 1.4 | 2.3 | 3.1 | 3.9 | 261.9 | · | · | |
| P/B | 13.1 | -8.7 | -7.9 | · | 5.2 | 1.7 | 1.9 | 1.0 | 5.9 | 5.9 | 3.0 | 2.3 | |
| P / Tangible Book | · | · | · | · | · | 9.2 | · | · | · | · | · | · | |
| P / Cash Flow | 6.3 | -10.5 | -10.3 | · | -1.6 | -3.8 | -3.0 | -6.6 | -12.6 | 6.9 | -7.6 | -8.6 | |
| P / FCF | 6.3 | -10.5 | -10.3 | · | -1.6 | -3.7 | -2.9 | -6.5 | -12.3 | 7.3 | -7.5 | -8.6 | |
| EV / EBITDA | 12.4 | -8.2 | -5.0 | · | -1.3 | -0.8 | -2.5 | · | · | · | · | · | |
| EV / FCF | 4.3 | -10.2 | -10.0 | · | -1.4 | -2.5 | -2.6 | · | · | · | · | · | |
| EV / Revenue | 1.2 | 2.6 | 1.2 | · | 1.6 | 1.0 | 2.1 | · | · | · | · | · | |
| Earnings Yield | -1.2% | -17.4% | -22.6% | -90.1% | -75.2% | -99.3% | -37.3% | -33.6% | -12.5% | · | · | · |
Gewinn- und Verlustrechnung 15
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $49M | $54M | $58M | $59M | $62M | $57M | $46M | $37M | $44M | $33M | $56M | $42M | $56M | $40M | $56M | $49M | |
| Cost of Revenue | $10M | $12M | $13M | $9M | $10M | $8M | $20M | $14M | $17M | $12M | $19M | $18M | $17M | $20M | $-3M | $38M | |
| R&D Expense | $14M | $15M | $27M | $15M | $11M | $10M | $12M | $8M | $8M | $10M | $10M | $13M | $20M | $20M | $32M | $28M | |
| SG&A Expense | $28M | $30M | $26M | $29M | $27M | $26M | $28M | $27M | $27M | $25M | $25M | $23M | $27M | $25M | $30M | $32M | |
| Operating Expenses | $45M | $46M | $54M | $45M | $38M | $36M | $40M | $36M | $35M | $36M | $36M | $37M | $48M | $45M | $64M | $61M | |
| Operating Income | $-6M | $-5M | $-9M | $4M | $14M | $14M | $-14M | $-13M | $-9M | $-15M | $1M | $-13M | $-9M | $-26M | $-5M | $-50M | |
| Other Non-op | $-7.0K | $3.0K | $-117.0K | $-10.0K | $-28.0K | $213.0K | $55.0K | $-17.0K | $-39.0K | $95.0K | $658.0K | $-43.0K | $-10.0K | $282.0K | $434.0K | $1M | |
| Pretax Income | $-9M | $-9M | $-11M | $1M | $247.0K | $6M | $-23M | $-20M | $-9M | $-18M | $612.0K | $-14M | $-11M | $-27M | · | · | |
| Income Tax | $70.0K | $126.0K | $1M | $615.0K | $0 | $0 | $0 | $0 | · | · | · | · | · | · | · | · | |
| Net Income | $-9M | $-9M | $-12M | $540.0K | $247.0K | $6M | $-23M | $-20M | $-9M | $-18M | $612.0K | $-14M | $-11M | $-27M | $-6M | $-54M | |
| EPS (Basic) | $-0.03 | $-0.03 | $-0.05 | $0.00 | $0.00 | $0.03 | $-0.10 | $-0.10 | $-0.04 | $-0.09 | $0.01 | $-0.08 | $-0.06 | $-0.15 | $-0.04 | $-0.29 | |
| EPS (Diluted) | $-0.03 | $-0.03 | $-0.05 | $0.00 | $0.00 | $0.03 | $-0.10 | $-0.10 | $-0.04 | $-0.09 | $0.01 | $-0.08 | $-0.06 | $-0.15 | $-0.03 | $-0.29 | |
| Shares (Basic) | 269,602,747 | 267,046,755 | -505,691,870 | 264,786,432 | 262,565,500 | 235,497,720 | -414,062,349 | 210,348,459 | 209,705,397 | 204,955,151 | -372,427,316 | 188,306,350 | 186,817,431 | 184,768,983 | -364,296,577 | 183,882,446 | |
| Shares (Diluted) | 269,602,747 | 267,046,755 | -529,921,813 | 274,372,722 | 271,104,020 | 241,602,853 | -414,062,349 | 210,348,459 | 209,705,397 | 204,955,151 | -372,427,316 | 188,306,350 | 186,817,431 | 184,768,983 | -371,074,128 | 183,882,446 | |
| EBITDA | $-6M | $-5M | · | $4M | $14M | $14M | · | $-13M | $-9M | $-15M | · | $-13M | $-9M | $-25M | · | $-48M |
Bilanz 25
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $156M | $163M | $185M | $166M | $137M | $113M | $52M | $34M | $39M | $42M | $43M | $47M | $54M | $57M | $90M | $145M | |
| Receivables | $54M | $63M | $47M | $66M | $73M | $62M | $34M | $32M | $30M | $27M | · | $23M | $20M | $18M | $40M | $23M | |
| Inventory | $13M | $13M | $16M | $19M | $17M | $20M | $16M | $20M | $24M | $26M | · | $18M | $21M | $21M | $22M | $40M | |
| Prepaid Expense | $7M | $5M | $5M | $7M | $8M | $9M | $11M | $13M | $19M | $19M | · | $22M | $24M | $25M | $33M | $30M | |
| Other Current Assets | $6M | $4M | $4M | $5M | $8M | $8M | $7M | $6M | $7M | $5M | · | · | · | · | $17M | · | |
| Current Assets | $230M | $243M | $253M | $258M | $235M | $204M | $114M | $100M | $112M | $113M | · | $110M | $118M | $121M | $185M | $238M | |
| PP&E (Net) | $2M | $956.0K | $1M | $1M | $2M | $2M | $2M | $3M | $3M | $3M | · | $4M | $4M | $5M | $5M | $6M | |
| Goodwill | $59M | $59M | $59M | $59M | $59M | $59M | $59M | $59M | $59M | $59M | · | $59M | $59M | $55M | $59M | $55M | |
| Intangibles | · | · | · | · | · | · | · | $9M | $18M | $27M | · | $45M | $54M | $63M | $72M | $81M | |
| Other Non-current Assets | $54M | $57M | $60M | $40M | $44M | $38M | $37M | $27M | $18M | $12M | · | $4M | $3M | $5M | $5M | $26M | |
| Total Assets | $350M | $363M | $377M | $364M | $346M | $310M | $221M | $207M | $220M | $225M | · | $235M | $254M | $277M | $356M | $436M | |
| Accounts Payable | $9M | $8M | $21M | $10M | $12M | $13M | $15M | $13M | $10M | $12M | · | $9M | $12M | $13M | $18M | $20M | |
| Accrued Liabilities | $110M | $125M | $122M | $106M | $92M | $71M | $63M | $52M | $54M | $54M | · | $63M | $56M | $46M | $76M | $87M | |
| Current Liabilities | $161M | $174M | $163M | $133M | $119M | $91M | $81M | $66M | $107M | $66M | · | $80M | $92M | $83M | $130M | $188M | |
| Capital Leases | $4M | · | $0 | $0 | $671.0K | $2M | $4M | $5M | $6M | $8M | · | $10M | $11M | $27M | $29M | $31M | |
| Other Non-current Liabilities | $562.0K | $681.0K | $2M | $5M | $5M | $5M | $5M | $5M | $7M | $7M | · | $9M | $17M | $13M | $16M | $74M | |
| Total Liabilities | $325M | $335M | $344M | $323M | $316M | $286M | $270M | $258M | $254M | $253M | · | $274M | $281M | $291M | $351M | $422M | |
| Long-term Debt | $50M | $49M | $48M | $48M | $47M | $47M | · | $38M | $38M | $30M | · | $43M | $42M | $50M | $66M | $66M | |
| Total Debt | $50M | $49M | · | $48M | $47M | $47M | · | $38M | $38M | $30M | · | $43M | $42M | $50M | · | $66M | |
| Common Stock | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | · | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | |
| Retained Earnings | $-1.70B | $-1.69B | $-1.68B | $-1.67B | $-1.67B | $-1.67B | $-1.68B | $-1.66B | $-1.64B | $-1.63B | · | $-1.61B | $-1.60B | $-1.58B | $-1.56B | $-1.55B | |
| AOCI | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | · | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | |
| Stockholders' Equity | $25M | $27M | $33M | $42M | $29M | $25M | $-49M | $-50M | $-34M | $-27M | $-31M | $-39M | $-27M | $-14M | $5M | $14M | |
| Liabilities + Equity | $350M | $363M | $377M | $364M | $346M | $310M | $221M | $207M | $220M | $225M | · | $235M | $254M | $277M | $356M | $436M | |
| Shares Outstanding | 271,742,717 | 267,898,415 | 265,424,818 | 265,226,038 | 263,041,832 | 261,644,590 | 224,848,992 | 211,542,122 | 209,929,145 | 209,454,149 | 194,582,539 | 188,313,807 | 188,128,869 | 185,835,946 | 184,135,714 | 183,951,583 |
Cashflow 9
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $3M | $4M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $2M | $3M | $3M | |
| Amort. of Intangibles | · | · | $0 | $0 | $0 | $0 | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | |
| Restructuring | $2M | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $58.0K | $0 | $169.0K | $-94.0K | $106.0K | $1M | $180.0K | |
| Operating Cash Flow | $4M | $-21M | $31M | $28M | $22M | $-14M | $-4M | $-7M | $-10M | $-19M | $-2M | $-7M | $4M | $-18M | $-55M | $34M | |
| CapEx | $1M | $62.0K | $70.0K | $77.0K | $126.0K | $18.0K | $2.0K | $2.0K | $29.0K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Investing Cash Flow | $-4M | $-62.0K | $-8M | $-77.0K | $-126.0K | $154.0K | $-2.0K | $-2.0K | $-29.0K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Financing Cash Flow | $-7M | $-926.0K | $-5M | $1M | $2M | $75M | $22M | $1M | $8M | $18M | $-1M | $50.0K | $-8M | $-16M | $-1.0K | $-33M | |
| Net Change in Cash | $-7M | $-22M | $18M | $29M | $24M | $62M | $18M | $-5M | $-2M | $-957.0K | $-4M | $-7M | $-4M | $-34M | $-55M | $868.0K | |
| Free Cash Flow | · | $-21M | · | · | · | $-14M | · | · | · | · | · | · | · | $-18M | · | · |
Rentabilität 7
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -12.9% | -8.8% | · | 7.6% | 22.6% | 23.6% | · | -33.4% | -20.0% | -45.8% | · | -31.0% | -16.0% | -62.2% | · | -98.4% | |
| Net Margin | -18.1% | -16.9% | · | 0.92% | 0.40% | 10.7% | · | -53.5% | -19.7% | -55.2% | · | -34.5% | -19.8% | -65.3% | · | -105.9% | |
| Pretax Margin | -18.0% | -16.7% | · | 2.0% | 0.40% | 10.7% | · | -53.5% | -19.7% | -55.2% | · | · | · | · | · | · | |
| EBITDA Margin | -12.9% | -8.8% | · | 7.6% | 22.6% | 23.6% | · | -33.4% | -20.0% | -45.8% | · | -31.0% | -16.0% | -62.2% | · | -98.4% | |
| ROA | -2.6% | -2.7% | · | 0.19% | 0.09% | 2.3% | · | -9.1% | -3.6% | -7.2% | · | -4.3% | -2.9% | -6.5% | · | -10.0% | |
| ROE | -32.9% | -34.8% | · | -12.3% | -10.9% | -456.6% | · | 44.6% | 28.3% | 86.5% | · | 113.3% | -62.9% | -445.7% | · | -68.7% | |
| ROIC | -8.6% | -6.2% | · | 2.3% | · | · | · | · | · | · | · | · | · | · | · | · |
Liquidität & Solvenz 4
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.4 | 1.4 | · | 1.9 | 2.0 | 2.2 | · | 1.5 | 1.0 | 1.7 | · | 1.4 | 1.3 | 1.5 | · | 1.3 | |
| Quick Ratio | 1.3 | 1.3 | · | 1.7 | 1.8 | 1.9 | · | 1.0 | 0.6 | 1.0 | · | 0.9 | 0.8 | 0.9 | · | 0.9 | |
| Debt / Equity | 2.0 | 1.8 | · | 1.1 | 1.6 | 1.9 | · | -0.8 | -1.1 | -1.1 | · | -1.1 | -1.6 | -3.5 | · | 4.8 | |
| LT Debt / Equity | 1.0 | 1.3 | · | 1.1 | 1.6 | 1.9 | · | -0.8 | -1.1 | -1.1 | · | -0.9 | -0.7 | -1.8 | · | · |
Effizienz 3
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.7 | 0.8 | · | 0.5 | 0.5 | 0.3 | · | 0.7 | 0.8 | 0.5 | · | 0.6 | 0.6 | 0.6 | · | 1.0 | |
| Receivables Turnover | 0.8 | 0.9 | · | 1.2 | 1.2 | 1.3 | · | 1.4 | 1.8 | 1.5 | · | 1.8 | 1.1 | 1.0 | · | 1.3 |
Bewertung (TTM) 13
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $224M | $232M | · | $216M | $201M | $171M | · | $156M | $175M | $171M | · | $187M | $271M | $277M | · | $286M | |
| Net Income TTM | $-17M | $-2M | · | $-13M | $-22M | $-40M | · | $-61M | $-52M | $-71M | · | $-107M | $-63M | $-115M | · | $-148M | |
| Market Cap | $310M | $372M | · | $724M | $957M | $502M | · | $279M | $214M | $383M | · | $215M | $172M | $104M | · | $58M | |
| Enterprise Value | $204M | $259M | · | $605M | $867M | $435M | · | $284M | $213M | $371M | · | $211M | $161M | $97M | · | $-21M | |
| P/E | -19.0 | · | · | -39.0 | -33.1 | -9.6 | · | -4.3 | -3.8 | -4.8 | · | -2.0 | -2.6 | -0.9 | · | -0.4 | |
| P/S | 1.4 | 1.6 | · | 3.4 | 4.8 | 2.9 | · | 1.8 | 1.2 | 2.2 | · | 1.1 | 0.6 | 0.4 | · | 0.2 | |
| P/B | 12.4 | 13.6 | · | 17.4 | 32.8 | 20.4 | · | -5.5 | -6.3 | -14.1 | · | -5.4 | -6.4 | -7.3 | · | 4.2 | |
| P / Cash Flow | · | -17.6 | · | · | · | -37.0 | · | · | · | -19.7 | · | · | · | -5.9 | · | · | |
| P / FCF | · | -17.5 | · | · | · | -36.9 | · | · | · | · | · | · | · | -5.9 | · | · | |
| EV / EBITDA | -32.2 | -55.1 | · | 136.0 | 61.6 | 32.2 | · | -22.7 | -24.4 | -24.9 | · | -16.2 | -17.9 | -3.9 | · | 0.4 | |
| EV / FCF | · | -12.2 | · | · | · | -32.0 | · | · | · | · | · | · | · | -5.6 | · | · | |
| EV / Revenue | 0.9 | 1.1 | · | 2.8 | 4.3 | 2.5 | · | 1.8 | 1.2 | 2.2 | · | 1.1 | 0.6 | 0.4 | · | -0.1 | |
| Earnings Yield | -5.3% | 0.00% | · | -2.6% | -3.0% | -10.4% | · | -23.5% | -26.5% | -20.8% | · | -50.9% | -38.2% | -114.3% | · | -262.7% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-03-31 | 2022-12-31 | |
|---|---|---|---|---|---|
| Umsatz | $236M | $160M | $195M | — | $292M |
| Betriebsgewinnmarge % | 10.0% | -31.5% | -23.8% | — | -27.6% |
| Nettoergebnis | $-5M | $-69M | $-52M | — | $-94M |
| Verwässerte EPS | $-0.02 | $-0.33 | $-0.28 | — | $-0.52 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-03-31 | 2022-12-31 | |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | 1.5 | -0.8 | -1.1 | — | — |
| Liquiditätsgrad | 1.6 | 1.4 | 1.2 | — | — |
| Quick Ratio | 1.4 | 1.1 | 0.8 | — | — |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-03-31 | 2022-12-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | $68M | $-41M | $-23M | — | $-73M |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 184 Einreicher · $87.7M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 43 (+12 vs. Vorquartal) | 35 (+9 vs. Vorquartal) | 59 (+14 vs. Vorquartal) | 36 (-14 vs. Vorquartal) | +11.5M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $12.907.243 | 11.322.143 | 14,72% | Aktien |
| SATTER MANAGEMENT CO., L.P. | $10.921.021 | 5.747.906 | 12,45% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $6.557.737 | 5.750.625 | 7,48% | Aktien |
| STATE STREET CORP | $6.145.572 | 5.390.853 | 7,01% | Aktien |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $4.871.250 | 4.273.026 | 5,55% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $3.644.130 | 3.196.605 | 4,15% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2.888.734 | 2.533.977 | 3,29% | Aktien |
| GOLDMAN SACHS GROUP INC | $2.779.842 | 2.438.458 | 3,17% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $2.777.807 | 2.436.673 | 3,17% | Aktien |
| VANGUARD GROUP INC | $2.715.740 | 1.686.795 | 3,10% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $2.622.499 | 2.300.438 | 2,99% | Aktien |
| Nantahala Capital Management, LLC | $2.280.000 | 2.000.000 | 2,60% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $2.176.029 | 1.908.797 | 2,48% | Aktien |
| FMR LLC | $2.132.467 | 1.870.585 | 2,43% | Aktien |
| Qube Research & Technologies Ltd | $2.028.866 | 1.779.707 | 2,31% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $1.395.318 | 1.223.963 | 1,59% | Aktien |
| CITIGROUP INC | $1.265.009 | 1.109.657 | 1,44% | Aktien |
| MANGROVE PARTNERS IM, LLC | $760.328 | 666.954 | 0,87% | Aktien |
| AMERIPRISE FINANCIAL INC | $703.205 | 616.846 | 0,80% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $672.396 | 589.821 | 0,77% | Aktien |
| TWO SIGMA ADVISERS, LP | $643.918 | 399.949 | 0,73% | Aktien |
| CHOREO, LLC | $641.162 | 562.423 | 0,73% | Aktien |
| Quantinno Capital Management LP | $640.820 | 562.123 | 0,73% | Aktien |
| Creative Planning | $622.144 | 545.740 | 0,71% | Aktien |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $606.265 | 531.813 | 0,69% | Aktien |
| MORGAN STANLEY | $584.591 | 512.799 | 0,67% | Aktien |
| PANAGORA ASSET MANAGEMENT INC | $531.832 | 466.519 | 0,61% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $493.325 | 354.910 | 0,56% | Aktien |
| Eversept Partners, LP | $486.888 | 427.095 | 0,56% | Aktien |
| BANK OF AMERICA CORP /DE/ | $473.308 | 415.182 | 0,54% | Aktien |
| CANADA PENSION PLAN INVESTMENT BOARD | $368.904 | 323.600 | 0,42% | Aktien |
| VIRTUS ADVISERS, LLC | $359.940 | 315.737 | 0,41% | Aktien |
| RHUMBLINE ADVISERS | $350.544 | 307.503 | 0,40% | Aktien |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | $336.186 | 294.900 | 0,38% | Aktien |
| ALPS ADVISORS INC | $310.379 | 272.262 | 0,35% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $307.391 | 269.641 | 0,35% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $304.722 | 267.300 | 0,35% | Verkaufsoption |
| FRANKLIN RESOURCES INC | $286.156 | 251.014 | 0,33% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $279.072 | 244.800 | 0,32% | Kaufoption |
| Vanguard Global Advisers, LLC | $251.440 | 220.561 | 0,29% | Aktien |
| Graham Capital Management, L.P. | $236.845 | 207.759 | 0,27% | Aktien |
| Bank of New York Mellon Corp | $227.323 | 199.406 | 0,26% | Aktien |
| Wealthspire Advisors, LLC | $205.203 | 180.002 | 0,23% | Aktien |
| CITADEL ADVISORS LLC | $190.608 | 167.200 | 0,22% | Verkaufsoption |
| BlackRock, Inc. | $189.909 | 166.587 | 0,22% | Aktien |
| Nuveen Asset Management, LLC | $186.464 | 98.139 | 0,21% | Aktien |
| Man Group plc | $177.151 | 155.396 | 0,20% | Aktien |
| Mariner, LLC | $175.851 | 154.256 | 0,20% | Aktien |
| MetLife Investment Management, LLC | $174.281 | 152.878 | 0,20% | Aktien |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $157.464 | 112.474 | 0,18% | Aktien |
| Russell Investments Group, Ltd. | $143.655 | 126.014 | 0,16% | Aktien |
| BARCLAYS PLC | $139.430 | 122.307 | 0,16% | Aktien |
| VIRGINIA RETIREMENT SYSTEMS ET Al | $136.850 | 85.000 | 0,16% | Aktien |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $135.666 | 119.005 | 0,15% | Aktien |
| MERCER GLOBAL ADVISORS INC /ADV | $127.402 | 111.756 | 0,15% | Aktien |
| Invesco Ltd. | $116.967 | 102.603 | 0,13% | Aktien |
| GROUP ONE TRADING LLC | $115.841 | 101.615 | 0,13% | Aktien |
| Fiduciary Trust Co | $114.000 | 100.000 | 0,13% | Aktien |
| CITADEL ADVISORS LLC | $110.580 | 97.000 | 0,13% | Kaufoption |
| LPL Financial LLC | $108.888 | 95.516 | 0,12% | Aktien |
| IEQ CAPITAL, LLC | $105.312 | 92.379 | 0,12% | Aktien |
| Jain Global LLC | $104.214 | 91.416 | 0,12% | Aktien |
| Focus Partners Wealth | $92.280 | 80.948 | 0,11% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $91.133 | 79.941 | 0,10% | Aktien |
| NEW YORK STATE COMMON RETIREMENT FUND | $90.174 | 79.100 | 0,10% | Aktien |
| Headlands Technologies LLC | $88.911 | 77.992 | 0,10% | Aktien |
| Abel Hall, LLC | $85.999 | 75.438 | 0,10% | Aktien |
| SEI INVESTMENTS CO | $84.797 | 74.383 | 0,10% | Aktien |
| D. E. Shaw & Co., Inc. | $82.699 | 72.543 | 0,09% | Aktien |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $81.957 | 71.892 | 0,09% | Aktien |
| OSAIC HOLDINGS, INC. | $79.715 | 69.926 | 0,09% | Aktien |
| Police & Firemen's Retirement System of New Jersey | $78.757 | 69.085 | 0,09% | Aktien |
| Brevan Howard Capital Management LP | $72.675 | 63.750 | 0,08% | Aktien |
| CITADEL ADVISORS LLC | $72.243 | 63.371 | 0,08% | Aktien |
| INTECH INVESTMENT MANAGEMENT LLC | $70.931 | 62.220 | 0,08% | Aktien |
| Squarepoint Ops LLC | $67.747 | 59.427 | 0,08% | Aktien |
| CWA Asset Management Group, LLC | $67.260 | 59.000 | 0,08% | Aktien |
| RAYMOND JAMES FINANCIAL INC | $65.585 | 57.531 | 0,07% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $63.105 | 55.355 | 0,07% | Aktien |
| Arax Advisory Partners | $62.700 | 54.999 | 0,07% | Aktien |
| VOYA INVESTMENT MANAGEMENT LLC | $61.941 | 54.334 | 0,07% | Aktien |
| CAPTRUST FINANCIAL ADVISORS | $61.567 | 54.006 | 0,07% | Aktien |
| JANE STREET GROUP, LLC | $59.280 | 52.000 | 0,07% | Kaufoption |
| PDS Planning, Inc | $57.000 | 50.000 | 0,06% | Aktien |
| Nuveen, LLC | $56.925 | 49.934 | 0,06% | Aktien |
| UBS Group AG | $52.834 | 46.346 | 0,06% | Aktien |
| PRUDENTIAL FINANCIAL INC | $50.028 | 43.884 | 0,06% | Aktien |
| NORTHERN TRUST CORP | $46.146 | 40.479 | 0,05% | Aktien |
| TWO SIGMA SECURITIES, LLC | $45.753 | 40.134 | 0,05% | Aktien |
| EP Wealth Advisors, LLC | $44.059 | 38.648 | 0,05% | Aktien |
| HighTower Advisors, LLC | $43.968 | 38.568 | 0,05% | Aktien |
| Gotham Asset Management, LLC | $41.100 | 36.053 | 0,05% | Aktien |
| Scientech Research LLC | $40.117 | 35.190 | 0,05% | Aktien |
| Empirical Asset Management, LLC | $39.900 | 35.000 | 0,05% | Aktien |
| ProShare Advisors LLC | $38.572 | 33.836 | 0,04% | Aktien |
| NEUBERGER BERMAN GROUP LLC | $37.783 | 33.143 | 0,04% | Aktien |
| CWM, LLC | $36.332 | 26.138 | 0,04% | Aktien |
| Tower Research Capital LLC (TRC) | $35.706 | 31.321 | 0,04% | Aktien |
| VICTORY CAPITAL MANAGEMENT INC | $34.394 | 30.170 | 0,04% | Aktien |
| Sonora Investment Management Group, LLC | $32.760 | 12.000 | 0,04% | Aktien |
Unternehmensinsider 29 Insider · 9 Führungskräfte · 17 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Erik Ostrowski | SVP, CFO, CBO & Treasurer | 29. Juni 2026 S | 616.616 | 0 | 1 | $-62.181 |
| David A Spellman | SVP, CFO and Treasurer | 30. Juni 2020 A | — | 0 | 0 | $0 |
| Jason Amello | SVP, CFO & Treasurer | 11. April 2019 D | 118.618 | 0 | 0 | $0 |
| Rita Jain | SVP, Chief Medical Officer | 11. April 2019 D | 96.332 | 0 | 0 | $0 |
| Michel Dahan | SVP, Chief Business Officer | 11. April 2019 D | 146.932 | 0 | 0 | $0 |
| Nicole R. Hadas | SVP, CLO & Secretary | 11. April 2019 D | 154.806 | 0 | 0 | $0 |
| Karen L Tubridy | SVP, Chief Development Officer | 11. April 2019 D | 55.324 | 0 | 0 | $0 |
| Bradley Maroni | SVP and Chief Medical Officer | 22. Februar 2016 A | 38.859 | 0 | 0 | $0 |
| Robert Shalwitz | Chief Medical Officer | 14. Mai 2014 A | 264.556 | 0 | 0 | $0 |
| Ron Frieson | Direktor | 17. Juni 2026 A | 165.200 | 0 | 0 | $0 |
| Myles Wolf | Direktor | 17. Juni 2026 A | 169.081 | 0 | 0 | $0 |
| Cynthia Smith | Direktor | 17. Juni 2026 A | 196.633 | 0 | 0 | $0 |
| Adrian Adams | Direktor | 17. Juni 2026 A | 236.200 | 0 | 0 | $0 |
| Michael W Rogers | Direktor | 17. Juni 2026 A | 197.429 | 0 | 0 | $0 |
| Leanne M Zumwalt | Direktor | 17. Juni 2026 A | 145.100 | 0 | 0 | $0 |
| Jodie Pope Morrison | Direktor | 12. Dezember 2018 A | 44.919 | 0 | 0 | $0 |
| Mark J Enyedy | Direktor | 12. Dezember 2018 A | 3.743 | 0 | 0 | $0 |
| Michael Thomas Heffernan | Direktor | 12. Dezember 2018 A | 7.486 | 0 | 0 | $0 |
| Steven C Gilman | Direktor | 12. Dezember 2018 A | 10.231 | 0 | 0 | $0 |
| Satter Muneer A | Direktor | 5. Juli 2017 P | 3.037.042 | 0 | 0 | $0 |
| Duane Nash | Direktor | 2. Oktober 2015 S | 31.609 | 0 | 0 | $0 |
| Anupam Dalal | Direktor | 10. Juni 2015 A | — | 0 | 0 | $0 |
| Michael D. Clayman | Direktor | 10. Juni 2015 A | — | 0 | 0 | $0 |
| Ronald C Renaud JR | Direktor | 10. Juni 2015 A | 5.000 | 0 | 0 | $0 |
| Maxine Gowen | Direktor | 10. Juni 2015 A | 1.300 | 0 | 0 | $0 |
| Michael S Wyzga | Direktor | 10. Juni 2015 A | 1.500 | 0 | 0 | $0 |
| John P. Butler | — | 6. August 2026 M | 3.718.564 | 0 | 0 | $0 |
| Novo Holdings A/S | — | 25. März 2014 C | 1.516.387 | 0 | 0 | $0 |
| Novartis Bioventures Ltd | — | 25. März 2014 C | 3.405.764 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 5 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Muneer A. Satter (2) ×3 Einreichungen | 11. Januar 2019 | — | Erste Einreichung | — | SEC |
| Nantahala Capital Management, LLC, Wilmot B. Harkey, Daniel Mack ×2 Einreichungen | 21. Dezember 2018 | — | Erste Einreichung | — | SEC |
| Vifor (International) Ltd., Vifor Pharma Ltd. ×2 Einreichungen | 10. August 2017 | — | Erste Einreichung | — | SEC |
| Kearny Venture Partners, L.P. (“KVP”), Kearny Venture Partners Entrepreneurs’ Fund, L.P. (“KVPE”), Thomas Weisel Healthcare Venture Partners, L.P. (“TWHVP”), Kearny Venture Associates, L.L.C. (“KVA”), Caley Castelein (“Castelein”), Richard Spalding (“Spalding”), James Shapiro (“Shapiro”) ×2 Einreichungen | 20. Januar 2016 | — | Erste Einreichung | — | SEC |
| Novo A/S ×3 Einreichungen | 18. November 2015 | — | Erste Einreichung | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 30 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,44% | 109.760 SH | 8. August 2026 | Täglich |
| SBIO · ALPS ETF Trust | 0,17% | 276.121 NS | 31. Mai 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,09% | 352.079 NS | 30. April 2026 | N-PORT |
| IWC · iShares Trust | 0,06% | 879.437 SH | 8. August 2026 | Täglich |
| GSSC · Goldman Sachs ETF Trust | 0,03% | 326.417 NS | 31. Mai 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,02% | 249.458 SH | 8. August 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,01% | 450.395 SH | 8. August 2026 | Täglich |
| SMLF · iShares Trust | 0,01% | 617.659 SH | 8. August 2026 | Täglich |
| IWO · iShares Trust | 0,01% | 2.117.247 SH | 8. August 2026 | Täglich |
| RSSL · Global X Funds | 0,01% | 111.420 NS | 30. April 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 1.485.665 SH | 8. August 2026 | Täglich |
| IWM · iShares Trust | 0,01% | 6.655.005 SH | 8. August 2026 | Täglich |
| ITWO · ProShares Trust | 0,01% | 11.916 NS | 31. Mai 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,01% | 1.262.655 NS | 31. Mai 2026 | N-PORT |
| UWM · ProShares Trust | 0,00% | 9.319 NS | 31. Mai 2026 | N-PORT |
| URTY · ProShares Trust | 0,00% | 9.423 NS | 31. Mai 2026 | N-PORT |
| IWN · iShares Trust | 0,00% | 337.593 SH | 8. August 2026 | Täglich |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 11.769 NS | 31. Mai 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 237 NS | 31. Mai 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 364.360 SH | 8. August 2026 | Täglich |
| DFAC · Dimensional ETF Trust | 0,00% | 108.459 NS | 30. April 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 6.918 NS | 30. April 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 45.708 SH | 8. August 2026 | Täglich |
| DFAU · Dimensional ETF Trust | 0,00% | 6.798 NS | 30. April 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,00% | 11.776 NS | 30. April 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 3.164.884 SH | 8. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 7.912.283 SH | 8. August 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,00% | 24.210 SH | 8. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 20.230 SH | 8. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,00% | 754.414 SH | 8. August 2026 | Täglich |